Navigation Links
HealthSouth to Present at J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference
Date:1/26/2009

BIRMINGHAM, Ala., Jan. 26 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) today announced it will participate in the J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference on Feb. 2-4, 2009, in Miami Beach, Fla.

HealthSouth Chief Financial Officer John Workman will be speaking on Tuesday, Feb. 3, at 8 a.m. EST. The presentation will be webcast live and may be accessed via the Investor Information section on the company's Web site at www.healthsouth.com.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitation services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves more than 250,000 patients annually through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitation services and can be found on the Web at www.healthsouth.com.

    Media Contact
    Andy Brimmer, 205-410-2777
    Investor Relations Contact
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com

'/>"/>
SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call
2. HealthSouth Reports Results for Third Quarter Ended September 30, 2008
3. HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance
4. HealthSouth Announces Plans to Build New Hospital in Arizona
5. HealthSouth to Hold Investor Meeting November 10, 2008
6. HealthSouth Finalizes Acquisition of Rehabilitation Unit at Medical Center of Arlington
7. HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital
8. HealthSouth Appoints Mary Ann Arico as SVP - Investor Relations and Corporate Communications
9. HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh has posted a new publication this ... generation is a time like no other and society needs to understand the only way ... does not want to sound like an old bible beater because religion has a bad ...
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional ... ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its ... products to all clients at reasonable prices. At the ECRM trade show, it had ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well ... VW+ 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and ... your workout. , After a successful launch in Sweden last year, the next ...
(Date:1/20/2017)... ... ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to support ... author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, his ... of age, he joined the Navy and got married right out of boot camp. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
Breaking Medicine Technology: